Pain intensity after robotic-assisted urological surgery: the PAIROU study an international prospective cohort study
An erratum to this article was published (Anaesth Crit Care Pain Med, Sep 2025 ↗)
Authors' conclusion
This large cohort study demonstrates that patients experience low pain scores and require low opioids after robotic-assisted urological surgery when commonly used multimodal analgesia protocols are administered.
Study context
- Population
- Patients scheduled for robotic-assisted urological surgery, 44 centres in EuropeNov 2022–Jun 2023
- Participants
- 965 patients
- Outcome
- Pain scores (numeric rating scale (NRS))
- Follow-up
- First day after surgery
Methodological detailsmulticentre, observational, international
- Multicentre
- Observational
- International
Main finding
As reported in the abstract
Pain score (NRS) on POD 1 · POD 1
Median pain score at rest (IQR, 0-4) (n = 963)
2
Median pain score with movement (IQR, 1-5) (n = 921)
3
Observational data: associations, not effects.
Secondary outcomes
Morphine equivalent consumption · 48 h after surgery
- Morphine equivalent consumption, mg (IQR 0-20 mg)
- 4
Safety
- Postoperative nausea and vomiting (PONV), % of patients (153/963)
- 16 %
Original publication
Pain intensity after robotic-assisted urological surgery: the PAIROU study an international prospective cohort study. Anaesth Crit Care Pain Med. Published 21 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →